Are PR3 positive and MPO positive GPA the same disease?

Fordham, Sarah and Mukhtyar, Chetan (2019) Are PR3 positive and MPO positive GPA the same disease? International Journal of Rheumatic Diseases, 22 Suppl 1. pp. 86-89. ISSN 1756-1841

Full text not available from this repository. (Request a copy)

Abstract

Granulomatosis with Polyangiitis is a necrotising systemic vasculitis predominantly affecting small and medium sized vessels. It is predominantly associated with antibodies directed against proteinase 3, but a small number of individuals with this disease have antibodies directed against myeloperoxidase. The premise of this paper is to explore the possibility that these two serotypes maybe two separate diseases. There is evidence that the same single nucleotide polymorphisms in the TLR 9 gene is associated with increased risk for PR3 ANCA positivity but protects against MPO ANCA positivity. There is some evidence that MPO ANCA positive GPA disease may be 'limited' in its expression and be associated with the more indolent phenotype. The genotype may affect the serotype, and the serotype might affect the phenotype. There has been limited success in identifying how the difference in phenotype might affect outcomes. We are at a very early stage in our understanding of how these serotypes might be treated differently. This paper attempts to critically appraise the evidence available so far.

Item Type: Article
Additional Information: © 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Uncontrolled Keywords: blood,blood,diagnosis, differential,genetic predisposition to disease,blood,humans,immunology,immunology,phenotype,polymorphism, single nucleotide,predictive value of tests,prognosis,risk factors,genetics
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 27 Nov 2019 01:59
Last Modified: 22 Apr 2020 08:23
URI: https://ueaeprints.uea.ac.uk/id/eprint/73090
DOI: 10.1111/1756-185X.13278

Actions (login required)

View Item View Item